General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback